Strategic Fit Quartesian is now part of Veranex, expanding integrated capabilities across product design, medical device evaluation, regulatory and market access. This presents a unified entry point for clients seeking end‑to‑end clinical data services within a broader healthcare technology ecosystem.

Clinical Data Expertise Specialized in clinical data services including statistical programming, data management, study design, and submission support. Sales opportunities exist with biopharma and medical device companies looking to accelerate trial timelines and improve data quality.

Technologies & Partners Established tech stack with Medrio, Veeva, WordPress, HubSpot and other tools indicates readiness to support modern eClinical workflows. Potential to upsell integrated solutions leveraging these platforms for clients already using or evaluating these technologies.

Growth & Acquisition History of partnerships and a major acquisition by Summit Partners to form Veranex signals strong financial backing and growth trajectory. This can reassure prospective clients about scale, reliability, and long‑term collaboration opportunities.

Market Positioning Revenue range and mid‑sized employee base position Quartesian as a flexible CRO alternative to larger firms. Target mid‑market biopharma and device companies seeking personalized service, faster cycles, and cost efficiencies from a focused data services partner.